Work

P5387LDL cholesterol, apolipoprotein B, lipoprotein(a), apolipoprotein CIII and triglyceride lowering by MGL-3196, a thyroid hormone beta selective agonist, in a 12 week study in HeFH patients

Year: 2018

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: European Heart Journal

DOI: 10.1093/eurheartj/ehy566.p5387

Authors: J J P Kastelein, I C Klausen, G K Hovingh, E Heggen, R Taub, G Langslet

Institutions: Amsterdam UMC Location University of Amsterdam, Regionshospitalet Viborg, Oslo University Hospital, Madrigal Pharmaceuticals (United States)

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2903892642

FWCI:

Cites:

Cited by:

Related to: 10